pcDNA3-BaLgp140-8his
(Plasmid
#100924)
-
PurposeMammalian expression plasmid for soluble gp140 from the BaL HIV-1 strain
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 100924 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1(+)
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5344
- Total vector size (bp) 7375
-
Vector typeMammalian Expression
-
Selectable markersNeomycin (select with G418)
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameHIV-1 (BaL) Env
-
Alt namegp140
-
Alt nameEnv
-
SpeciesHuman immunodeficiency virus 1
-
Insert Size (bp)2031
-
MutationCodon-optimized synthetic gene
-
GenBank IDAAA44191.1
- Promoter CMV
-
Tags
/ Fusion Proteins
- CD5 leader sequence (N terminal on insert)
- Purification tag after D664 is GSGSGGSGHHHHHHHH (C terminal on insert)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site NheI (not destroyed)
- 3′ cloning site XhoI (not destroyed)
- 5′ sequencing primer CMV_fwd
- 3′ sequencing primer BGH-rev (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3-BaLgp140-8his was a gift from Erik Procko (Addgene plasmid # 100924 ; http://n2t.net/addgene:100924 ; RRID:Addgene_100924) -
For your References section:
Conformational engineering of HIV-1 Env based on mutational tolerance in the CD4 and PG16 bound states. Heredia JD, Park J, Choi H, Gill KS, Procko E. J Virol. 2019 Mar 20. pii: JVI.00219-19. doi: 10.1128/JVI.00219-19. 10.1128/JVI.00219-19 PubMed 30894475